Literature DB >> 10810425

Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis.

P I Hsu1, K H Lai, E J Chien, C K Lin, G H Lo, H S Jou, J S Cheng, H H Chan, J H Hsu, L P Ger, P N Hsu, H H Tseng.   

Abstract

BACKGROUND: This study investigates the cell proliferation and the expression of p53 protein in Helicobacter pylori (H. pylori)-associated gastritis and assesses the effect of bacterial eradication on these epithelial factors.
MATERIAL AND METHODS: Seventy-nine patients with H. pylori-associated gastritis were randomized into the control group (n = 38) and anti-H. pylori group (n = 41). Each patient received endoscopic examinations with gastric biopsy before and 8 weeks after the treatment. The specimens from gastric antrum were immunostained for monoclonal antibodies against the proliferating cell nuclear antigen (PCNA) and p53 protein.
RESULTS: In the control group, the total labeling index (L.I.) of PCNA and the positive index (P.I.) of p53 in the whole foveolar epithelium were unchanged after treatment. In the anti-H. pylori group, 35 of 41 cases (85.3%) achieved eradication of H. pylori. Amongst the H. pylori-eradicated cases, the total L.I. of PCNA in the whole foveolar epithelium did not meaningfully alter after H. pylori elimination (p > 0.05). However, a significant reduction of L.I. was observed in the middle compartments of the gastric pits (before vs. after treatment: 14.0 vs. 7.3, p < 0.05). With regard to the p53 expression, the P.I.s were significantly decreased in the whole foveolar epithelium (before vs. after treatment: 0.57 vs. 0.17, p < 0.05) and in each compartment of the gastric pits (before vs. after treatment: [upper compartment]: 0.34 vs. 0.15, p < 0.05; [middle compartment]: 0.67 vs. 0.23, p < 0.05; [lower compartment]: 0.71 vs. 0.20, p < 0.05) after eradication of H. pylori.
CONCLUSIONS: Bacterial eradication reverses the hyperproliferating status of the foveolar epithelium in patients with H. pylori gastritis and leads to a decrease in p53 accumulation in the epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810425

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Polymerase chain reaction: a sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers.

Authors:  Ching-Chu Lo; Kwok-Hung Lai; Nan-Jing Peng; Gin-Ho Lo; Hui-Hwa Tseng; Chiun-Ku Lin; Chang-Bih Shie; Chao-Ming Wu; Yu-Shan Chen; Wen-Keui Huang; Angela Chen; Ping-I Hsu
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

2.  Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori.

Authors:  S Maeda; H Yoshida; Y Mitsuno; Y Hirata; K Ogura; Y Shiratori; M Omata
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

3.  Long-term administration of the fungus toxin, sterigmatocystin, induces intestinal metaplasia and increases the proliferative activity of PCNA, p53, and MDM2 in the gastric mucosa of aged Mongolian gerbils.

Authors:  Masahiro Kusunoki; Junichi Misumi; Tatsuo Shimada; Kazuo Aoki; Noritaka Matsuo; Hideaki Sumiyoshi; Takeshi Yamaguchi; Hidekatsu Yoshioka
Journal:  Environ Health Prev Med       Date:  2011-01-13       Impact factor: 3.674

4.  Gastric epithelial proliferation and p53 and p21 expression in a general population sample: relations to age, sex, and mucosal changes associated with H. pylori infection.

Authors:  Fredrik Petersson; Kurt Borch; Lennart E Franzén
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

5.  Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori.

Authors:  S Maeda; H Yoshida; Y Mitsuno; Y Hirata; K Ogura; Y Shiratori; M Omata
Journal:  Mol Pathol       Date:  2002-10

6.  Eradication of Helicobacter pylori Infection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium.

Authors:  Konstantinos Triantafyllou; Vasilios Papadopoulos; Theodoros Emanouil; Paraskevas Gkolfakis; Vasileia Damaskou; Georgios Tziatzios; Ioannis G Panayiotides; Irene Vafiadis; Spiros D Ladas
Journal:  Clin Med Insights Gastroenterol       Date:  2016-11-17

7.  7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan.

Authors:  Sung-Shuo Kao; Wen-Chi Chen; Ping-I Hsu; Kwok-Hung Lai; Hsien-Chung Yu; Hui-Hwa Cheng; Nan-Jing Peng; Chiun-Ku Lin; Hoi-Hung Chan; Wei-Lun Tsai; Huay-Min Wang; Tzung-Jiun Tsai; Kung-Hung Lin; Feng-Woei Tsay
Journal:  Gastroenterol Res Pract       Date:  2012-07-22       Impact factor: 2.260

8.  Biological markers in Helicobacter pylori-associated gastritis and carcinoma: the value of a scoring system.

Authors:  Walid A Mourad; Gamal El Husseiny; Mohamed Shoukri; Mohamed Rezeig; Nikolaus Chianzantoniou; Tarek Amin
Journal:  Ann Saudi Med       Date:  2004 Mar-Apr       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.